Moderna Secures $590M Grant for Bird Flu Vaccine
Moderna, a biotech firm, has received a $590 million award from the US government to accelerate development of an mRNA-based vaccine against bird flu. The company’s Phase 1/2 study on mRNA-1018 candidate showed positive results in healthy adults aged 18 and up. Moderna plans to move to a Phase 3 trial. As bird flu continues … Read more